Join us on September 23rd for the 23rd Annual Life Sciences BC Awards presented by FARRIS, an opportunity to celebrate the life science sector’s many achievements amongst peers, family, and friends. As Canada’s fastest-growing life sciences sector, our British Columbia ecosystem has never been stronger seeing unprecedented momentum in scientific discovery, innovation, and attraction of capital and talent.
The Life Sciences BC annual award is our moment to acknowledge and honour the efforts of all those who have invested their life’s work in advancing successful health innovations.
|
|
BioLinks in its usual format is taking a short break until Labour Day. Though the Life Sciences BC team continues to keep an eye on Member and Industry News, our team report switches to featuring our member benefits over the next few weeks. Along with workshops and other events, self-serve news and job postings, our members also have access to more than 30 discount offers, available on travel, lab supplies, office, and more. |
|
As a Life Sciences BC member, organizations and their employees can benefit from significant savings on a range of business and personal services. Click the links below to find out about our latest deals and savings on Human Resources and Programs:
|
|
|
|
Sweet Pharma Day is back again this year in a virtual format. Canadian biotech start-ups are invited to apply! |
|
|
|
MONTREAL, QB — Novartis Pharmaceuticals Canada Inc. in partnership with C2 International is hosting the first-ever Biome Summit in Canada. A unique, collaborative multi-stakeholder platform, the Summit this year aims to address the pressing issue of cardiovascular disease across the country. READ MORE
|
|
|
|
VANCOUVER, BC & BASEL, CH – Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced that it has entered into a global collaboration and license agreement with Takeda Pharmaceutical Company Limited for the development and commercialization of novel nonviral gene therapies to treat up to two undisclosed rare liver diseases. READ MORE
|
|
|
|
NEW YORK & CAMBRIDGE, Mass – Pfizer Inc. and Trillium Therapeutics Inc. today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. READ MORE
|
|
|
|
BURNABY, BC — Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, today announced the appointment of Christopher Kenney, M.D. as Chief Medical Officer, effective immediately. Dr. Kenney will oversee all clinical development and medical affairs strategies, guiding the development of Xenon’s portfolio of neurology-focused therapeutic programs. READ MORE
|
|
|
|
It’s no secret how important a company’s quality assurance (QA) and quality control (QC) professionals are to its long-term success. Maximize the potential of your profession in Canada’s rapidly growing bio-economy. Take part in BioTalent Canada’s National Occupational Standards (NOS) validation survey for Canada’s bio-economy. Your insights ensure the NOS reflects the current skills, education and credentialing required by the industry.
Currently, BioTalent is looking for input from the following roles:
- Quality Assurance Manager
- Quality Control Analyst
- Quality Control Specialist
|
|
|
|
The Pharmaceutical Sciences Group Inc. has several upcoming events:
Take advantage of an early bird promotion to save 15% on tickets until August 31, 2021 for all the events above.
|
|
|
|
The San Diego office of the Trade Commissioner Service of Canada has developed SoCal Biotech Highway, a program designed to provide guidance and high-touch strategic advisory services to early-stage biotech companies. Drug development companies that are looking to either launch innovative technologies towards commercialization or grow their portfolio of existing products into new therapeutic areas can benefit from a tailored strategic approach. The SoCal Biotech Highway will help Canadian executives foster better relationships with global pharmaceutical executives, and advise on how best to raise capital from investors in California. Apply here
|
|
 |
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients, believing science and compassion must work together to transform lives.
|
|
|
|
Cuprous works with partners to develop small molecule nanomedicines with particular focus in the following disease indications.Cuprous' Metaplex technology can be used to improve therapeutic activity of anticancer agents and create novel immunotherapeutics. Cuprous is also developing technologies to enhance immunotherapeutic effects of small molecules and to boost therapeutic activity of other modalities of immunotherapy such as checkpoint inhibitors, oncolytic viruses, and peptide vaccines.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here
|
|
|
|
Post A Job on the LSBC Website |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
